The objectives of the Media Preparation and Glassware Washing Shared Resource are to provide an efficient and reliable distribution of the product media at the lowest possible cost to the investigator while offering a wide variety of purchasing choices and to provide an efficient washing facility that will result in cost savings to the investigator and, at the same, will meet research requirements of clean and sterile glassware. The Media shared resource offers the research investigator two options: 1) Media prepared to follow specifications additives and pH parameters, as required by the investigator. Raw powdered media and special additives are provided by each individual investigators Preparation includes a step by step mixing sterile filtration, bottling and capping of the product. After bottling , media is label-identified and refrigerated until delivery to the investigator. 2) Media ordered from Life Technologies Cell Culture Products by individual researchers and processed by the shared resource. Purchased items are accepted from Life Technologies and distributed to the various laboratories from a central location by the CCC delivery service. Flyers are sent out bimonthly to all CCC members and each working lab is e-mailed quarterly updating the services offered. The Glassware Washing shared resource operates two separate washing facilities for 52 members within the CCC. There has been steady growth in amount of glassware washed and the number of members served. Each facility has an automatic washer with variable timing and multiple rinse cycles, autoclaves, automatic pipette stuffer and drying ovens. Additional services provided are pickup of dirty glassware from, and delivery of clean glassware from, and delivery of clean glassware to, investigator laboratories, hand rinsing, hot air and steam sterilization, acid washing, waste autoclaving, clean glassware storage, and the availability of a Type 1 pure water production system for laboratory usage. These facilities also act as a resource for specialized washing procedures.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-27
Application #
6563729
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Shu, Yi; Yin, Hongran; Rajabi, Mehdi et al. (2018) RNA-based micelles: A novel platform for paclitaxel loading and delivery. J Control Release 276:17-29
Scoville, Steven D; Nalin, Ansel P; Chen, Luxi et al. (2018) Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function. Blood 132:1792-1804
McMillan, Elizabeth A; Ryu, Myung-Jeom; Diep, Caroline H et al. (2018) Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer. Cell 173:864-878.e29
Schimizzi, Gregory V; Jin, Linda X; Davidson 4th, Jesse T et al. (2018) Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB (Oxford) 20:332-339
Fu, Xinping; Tao, Lihua; Wang, Pin-Yi et al. (2018) Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles. Oncotarget 9:21348-21358
Brewington, Beatrice Y; Shao, Yusra F; Davidorf, Fredrick H et al. (2018) Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions. Clin Ophthalmol 12:925-934
Doogan, Nathan J; Cooper, Sarah; Quisenberry, Amanda J et al. (2018) The role of travel distance and price promotions in tobacco product purchase quantity. Health Place 51:151-157
Byrd, John C; Ruppert, Amy S; Heerema, Nyla A et al. (2018) Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance). Blood Adv 2:1705-1718
Oblinger, Janet L; Burns, Sarah S; Huang, Jie et al. (2018) Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol 299:299-307
Pan, Pan; Oshima, Kiyoko; Huang, Yi-Wen et al. (2018) Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. Int J Cancer 143:886-896

Showing the most recent 10 out of 2602 publications